Effective control of leukemia

Blood cancer develops when white blood cells increase in number uncontrollably and overwhelm healthy cells in the bone marrow.

The exact causes of these abnormalities are not yet fully understood, but risk factors may include gene mutations and exposure to carcinogenic chemicals.

Leukemia: Appropriate therapies to enhance recovery

Acute leukemia is curable with definitive treatments. Cure rates depend on the subtype of acute leukemia. For some patients who are not healthy enough for aggressive treatment, advanced therapies can still help prolong life. For older patients who cannot tolerate high-dose chemotherapy, lower-dose chemotherapy combined with targeted therapies has been shown to improve survival rates. Treatment options are now personalized, focusing on the patient's specific cancer information and health status.

Lymphoma: The goal is complete remission.

Lymphoma is one of the more treatable forms of cancer, with the goal often being complete remission, meaning the absence of any signs of cancer. For slow-growing lymphomas, treatment is often delayed until necessary. Conversely, fast-growing lymphomas such as diffuse large B-cell lymphoma (DLBCL) usually require immediate treatment with advanced medications. These include conjugated monoclonal antibodies, a type of targeted therapy designed to inhibit cancer cell growth, which has shown effective remission in cases of diffuse large B-cell lymphoma (DLBCL).

Multiple myeloma: Towards a Potential Treatment

Multiple myeloma remains incurable; however, ongoing advancements in immunotherapy, targeted therapy, and cell therapy have transformed the treatment landscape, turning it from a cancer into a manageable chronic disease. Patients with multiple myeloma now experience longer remission periods and improved quality of life, continuing their daily activities as normal.

The developing treatments are incredibly promising and hold great promise for leukemia patients, underscoring the importance of specialized oncology care and managing these complex diseases.

Dr. Colin Phipps - Hematology & Blood Oncology Specialist at Parkway Cancer Centre, Mount Elizabeth Hospital Singapore

Dr. Colin Phipps Diong - Hematology & Blood Oncology Specialist at Parkway Cancer Centre, Mount Elizabeth Hospital Singapore, specializes in: lymphoma, leukemia, blood cancer, multiple myeloma, stem cell transplantation, etc.

For more details and to receive advice from Dr. Colin Phipps , please contact:

Parkway Healthcare Group (IHH Healthcare Singapore) Representative Office in Hanoi

110 Ba Trieu Street, Hai Ba Trung District, Hanoi.

Hotline: 0988 155 855 or 084 308 3637

Email: info@parkway.com.vn

FB page: https://www.facebook.com/parkwayhanoi

Thu Nguyen

Source: https://giadinh.suckhoedoisong.vn/kiem-soat-ung-thu-mau-hieu-qua-172250212083319648.htm